Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here


Gov. Christie, Pharma Executives and Federal Leaders Discuss Public-Private Partnership to Address Opioid Epidemic

Governor Chris Christie

Trenton, NJ, September 19, 2017 — Governor Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Crisis, yesterday joined Kellyanne Conway, Counselor to the President, and Former U.S. Rep. Patrick Kennedy, a commission member, in a roundtable at the War Memorial with leaders of the pharmaceutical industry, the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) to advance a public-private partnership that can address America’s epidemic of addiction.

Governor Christie said, “The public and private sectors must join together to address this public health crisis and act quickly to stop an epidemic delivering a death toll equivalent to America enduring another 9-11 attack every two and a half weeks.” Continue reading

White House Opioid Commission Urges Trump: ‘Declare a National Emergency’ on Drug Overdoses; Chaired by Gov. Christie

Washington, DC, August 1, 2017 — Christopher Ingraham reports in The Washington Post that the President’s Commission on Combating Drug Addiction and the Opioid Crisis, chaired by Gov. Chris Christie, issued a preliminary report on Monday stating that its “first and most urgent recommendation” is for the president to “declare a national emergency under either the Public Health Service Act or the Stafford Act.”

“With approximately 142 Americans dying every day,” the report notes, “America is enduring a death toll equal to September 11th every three weeks.” Continue reading

Gov. Christie Reportedly Will Join White House Opioid Effort; Part of Effort Led by Jared Kushner

Governor Chris Christie

Washington, DC, March 28, 2017 — The Associated Press reports that Gov. Chris Christie is expected to join a White House effort to combat opioid abuse.

A White House official said Monday that the governor would work on an opioid task force that will be announced later this week.  The official spoke on the condition of anonymity to discuss the plans in advance.

The Governor has dedicated his final year in office to curbing heroin and prescription drug addiction in New Jersey, advancing an ambitious policy agenda. Continue reading

Rutgers Interview: New Treatment Delivery Methods of Medication for Opioid Addiction Show Promise

Dr. Petros Levounis

New Brunswick, NJ, March 3, 2017 — Rutgers Today’s Patti Verbanas spoke to Petros Levounis, professor and chair of the Department of Psychiatry at Rutgers New Jersey Medical School and a member of the board of directors at the American Society of Addiction Medicine, about recent advancements in opioid treatment delivery methods and the most effective combination of therapies for recovery.

Every day, 91 Americans die from an opioid overdose, according to the Centers for Disease Control and Prevention.  Nationwide, physicians and legislators are ramping up efforts to stem the escalating heroin and prescription opioid addiction crisis. Continue reading

Gov. Christie Signs Executive Order Declaring Opioid Drug Abuse a Public Health Crisis; Creates Drug Abuse Task Force

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, January 18, 2017 — Intensifying his Administration’s commitment in the fight against substance abuse, Governor Chris Christie yesterday signed Executive Order 219 declaring the opioid epidemic a public health crisis in New Jersey.

The action requires the marshalling of all appropriate resources to combat its harmful effects on state citizens.

“We must take aggressive action to get this insidious crisis under control so I am calling together all resources of state government in order to save lives,” said Governor Christie. Continue reading

Governor Christie Delivers 2017 State of the State Address; Focus Is on Combatting Drug Addiction

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, January 10, 2017Governor Chris Christie delivered his 2017 State of the State Address this afternoon before members of the State Legislature. 

The following is the Governor’s address as Prepared for Delivery today:

This is the seventh time I have had the honor to step before the Legislature and the people of New Jersey to perform one of my duties as Governor. Article V, Section I, Paragraph 12 creates the constitutional requirement to report on the State of the State. As the one person independently elected by all New Jerseyans to state government, the Governor is the only person truly able to give the people this report.

For me, service to the people of this state has been my central responsibility every day of my life for the last fifteen years, first as U.S. Attorney and now as Governor. As I enter my eighth year as Governor, it is my honor and privilege to report on the State of the State I call home for me and my family. Continue reading

21st Century Cures Bill Released; House to Vote Wednesday on $6.3 Billion Medical Innovation Package

Capitol Building flagWashington, DC, November 28, 2016 — U.S. House of Representatives and Senate health committee leaders have released the final “21st Century Cures” bill.

In addition, the leaders announced that the House will vote Wednesday on a $6.3 Billion landmark medical innovation package that will accelerate the discovery, development, and delivery of new cures and treatments and provide new funding for the National Institutes of Health (NIH) and Food and Drug Administration (FDA).

The leaders said the House also will vote Wednesday to include in the Cures bill legislation that updates major mental health programs for the first time in a decade.   Continue reading

Congress Sends First Major Opioids Legislation to President Obama’s Desk

Opioid Abuse 2Washington, DC, July 14, 2016 — Dylan Scott reports on STAT that the first major legislation to address the growing crisis of opioid addiction is on its way to President Obama’s desk, after the Senate approved the package in a strong bipartisan vote on Wednesday.

In a show of the widespread agreement for action, 92 senators voted for the bill after it received more than 400 votes in the House last week.

The legislation, called the Comprehensive Addiction and Recovery Act, is a compilation of measures passed by the House and Senate in recent weeks to try to fight the epidemic of addiction to painkillers, which is now killing nearly 30,000 people annually in the United States. Continue reading

PhRMA CEO Stephen Ubl Writes on ‘Combatting Opioid Abuse’

Stephen J. Ubl

Washington, DC, May 22, 2016 Pharmaceutical Research and Manufacturers of America (PhRMA) President and Chief Executive Officer Stephen J. Ubl on May 19 wrote on combatting opioid drug abuse in the nation in Morning Consult:

Mr. Ubl wrote:

More Americans are addicted to prescription pain medications than there are people living in San Diego and Washington, D.C. — combined.

Of those nearly two million people, 19,000 of them will die this year from an overdose involving prescription drugs, while American employers will lose more than $10 billion this year due to lost productivity.

We also cannot ignore the fact that pain is cited as the most common reason Americans seek out health care.  It is a leading cause of disability and a major contributor to health care costs. Ninety percent of patients with advanced cancer experience severe pain, and pain occurs in 30 percent of all patients with cancer, regardless of the stage of their disease. Continue reading

FDA Panel Recommends Training Physicians on Painkiller Drugs

Opioid Abuse 1Washington, DC, May 5 ― The Associated Press reports that doctors who prescribe painkillers should be required to undergo training aimed at reducing misuse and abuse of the medications, according to federal health experts, though they acknowledge the challenge of putting such a mandate in place.

The group of advisers to the Food and Drug Administration voted unanimously Wednesday that the agency should change its risk-management programs for opioid painkillers, highly addictive medications at the center of a national epidemic of addiction and abuse.

Panelists said the risk plans should apply to all prescription painkillers, including immediate-release drugs like Vicodin and Percocet.  Currently, the measures only apply to long-acting drugs like OxyContin, which slowly release their ingredients over 12 hours or more. Continue reading